Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets urged to vaccinate rabbits against RHD-2
RHD2 is a devastating disease that is highly fatal to unvaccinated rabbits.

British Rabbit Council shares its concerns

Vets are being urged to make rabbit hemorrhagic disease type 2 vaccine (RHD-2) part of their core rabbit vaccination programme.

In a letter to Vet Record (Vol 181 No 19), Sarah Elliott of the British Rabbit Council and Richard Saunders of the Rabbit Welfare Association
share their concerns that some vets are telling owners that vaccination is not required.

They write: ‘We have been concerned to hear that, following breeders recommending that newly acquired pet rabbits are taken to their vet for vaccination, some owners are being told that this is not necessary.

‘A recurring conversation at rabbit shows and on public social media has been that pet rabbit owners know nothing about RHD-2 despite having their rabbits vaccinated yearly against myxomatosis and RHD-1.

‘We would also ask that if a breeder approaches a vet to source and provide vaccine for them that you assist with this. Some breeders have a large number of rabbits and we would ask that you offer a site visit to vaccinate their stock.’

RHD2 is a devastating disease that is highly fatal to rabbits that have not been vaccinated. Since it's discovery in the UK in 2010, the disease has spread throughout much of the country and is now more dominant than RHD-1.

In October 2016, following concerns over a lack of vaccine, the European Medicines Agency issued a marketing authorisation for the vaccine ERAVAC to reduce mortality. This was later followed by Filavic, which received its UK licence in April 2017.

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk